BL Pharmtech Corp. (KOSDAQ:065170)
3,645.00
-265.00 (-6.78%)
At close: Jul 10, 2026
BL Pharmtech Revenue
BL Pharmtech had revenue of 1.52B KRW in the quarter ending March 31, 2026, a decrease of -49.23%. This brings the company's revenue in the last twelve months to 5.04B, down -39.57% year-over-year. In the year 2025, BL Pharmtech had annual revenue of 6.51B, down -26.12%.
Revenue (ttm)
5.04B
Revenue Growth
-39.57%
P/S Ratio
20.20
Revenue / Employee
419.64M
Employees
12
Market Cap
101.73B
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.51B | -2.30B | -26.12% |
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 330.05B |
| H.PIO | 266.01B |
| DongKoo Bio & Pharma | 242.08B |
| Kyung Dong Pharmaceutical | 198.27B |
| GC WellBeing | 179.05B |
| HYUNDAI BIOLAND | 135.04B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 108.89B |
| OPTUS Pharmaceutical | 91.62B |